284 related articles for article (PubMed ID: 30603857)
21. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
Veronesi U; Orecchia R; Maisonneuve P; Viale G; Rotmensz N; Sangalli C; Luini A; Veronesi P; Galimberti V; Zurrida S; Leonardi MC; Lazzari R; Cattani F; Gentilini O; Intra M; Caldarella P; Ballardini B
Lancet Oncol; 2013 Dec; 14(13):1269-77. PubMed ID: 24225155
[TBL] [Abstract][Full Text] [Related]
22. High-dose-rate brachytherapy boost effect on local tumor control in young women with breast cancer.
Guinot JL; Baixauli-Perez C; Soler P; Tortajada MI; Moreno A; Santos MA; Mut A; Gozalbo F; Arribas L
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):165-71. PubMed ID: 25446608
[TBL] [Abstract][Full Text] [Related]
23. [Brachytherapy of breast cancer].
Chand MÈ; Rivera S; Hennequin C; Hannoun-Lévi JM; Quero L
Cancer Radiother; 2013 Apr; 17(2):125-9. PubMed ID: 23453755
[TBL] [Abstract][Full Text] [Related]
24. Limited-field radiation therapy in the management of early-stage breast cancer.
Vicini FA; Kestin L; Chen P; Benitez P; Goldstein NS; Martinez A
J Natl Cancer Inst; 2003 Aug; 95(16):1205-10. PubMed ID: 12928345
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
26. Tumor bed boost omission after negative re-excision in breast-conservation treatment.
Arthur DW; Cuttino LW; Neuschatz AC; Koo DT; Morris MM; Bear HD; Kaplan BJ; Dawson K; Wazer DE
Ann Surg Oncol; 2006 Jun; 13(6):794-801. PubMed ID: 16614879
[TBL] [Abstract][Full Text] [Related]
27. Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast-conserving surgery and irradiation.
Fein DA; Fowble BL; Hanlon AL; Hoffman JP; Sigurdson ER; Eisenberg BL
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1009-17. PubMed ID: 8600083
[TBL] [Abstract][Full Text] [Related]
28. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?
Vrieling C; Collette L; Fourquet A; Hoogenraad WJ; Horiot JC; Jager JJ; Bing Oei S; Peterse HL; Pierart M; Poortmans PM; Struikmans H; Van den Bogaert W; Bartelink H;
Eur J Cancer; 2003 May; 39(7):932-44. PubMed ID: 12706362
[TBL] [Abstract][Full Text] [Related]
29. Interstitial high-dose-rate brachytherapy after breast conserving surgery.
Rulli A; Barberini F; Scialpi M; Izzo L; D'Angeli I; Gori S; Sidoni A; Rondelli F; Noya G; Aristei C
Oncol Rep; 2010 Aug; 24(2):417-22. PubMed ID: 20596628
[TBL] [Abstract][Full Text] [Related]
30. Postmastectomy radiotherapy of the chest wall. Comparison of electron-rotation technique and common tangential photon fields.
Hehr T; Classen J; Huth M; Durst I; Christ G; Bamberg M; Budach W
Strahlenther Onkol; 2004 Oct; 180(10):629-36. PubMed ID: 15480511
[TBL] [Abstract][Full Text] [Related]
31. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.
Budrukkar AN; Sarin R; Shrivastava SK; Deshpande DD; Dinshaw KA
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):596-603. PubMed ID: 17706403
[TBL] [Abstract][Full Text] [Related]
32. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients.
Reitsamer R; Peintinger F; Sedlmayer F; Kopp M; Menzel C; Cimpoca W; Glueck S; Rahim H; Kopp P; Deutschmann H; Merz F; Brandis M; Kogelnik H
Eur J Cancer; 2002 Aug; 38(12):1607-10. PubMed ID: 12142049
[TBL] [Abstract][Full Text] [Related]
34. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy.
Lupe K; Truong PT; Alexander C; Lesperance M; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e561-8. PubMed ID: 21514069
[TBL] [Abstract][Full Text] [Related]
35. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
Poortmans PM; Collette L; Bartelink H; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Hoogenraad W; Müller RP; Dubois JB; Bolla M; Van Der Hulst M; Wárlám-Rodenhuis CC; Pierart M; Horiot JC;
Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Horwitz EM; Lacerna MD; Dmuchowski CF; Brown DM; White J; Chen PY; Edmundson GK; Gustafson GS; Clarke DH; Gustafson GS; Matter RC; Martinez AA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):845-52. PubMed ID: 9128961
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
[TBL] [Abstract][Full Text] [Related]
38. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
39. Oncological outcome, postoperative complications, and mammographic changes after intraoperative radiotherapy with electrons (IOERT) as a boost in a large single-institution cohort of breast cancer patients.
Machiels M; Weytjens R; Erven K; Westerhoff JM; Amrouch S; Bosiers J; Verkinderen L; Hauspy J; van Dam P; Stevens P; Bernaerts A; Strijbos M; Meijnders P; Dirix P; Verellen D; Van Laere S; Vermeulen PB; Billiet C
Breast J; 2020 Oct; 26(10):1937-1945. PubMed ID: 32779870
[TBL] [Abstract][Full Text] [Related]
40. Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group.
Liljegren G; Holmberg L; Adami HO; Westman G; Graffman S; Bergh J
J Natl Cancer Inst; 1994 May; 86(9):717-22. PubMed ID: 8158702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]